The Eijkman-Oxford Clinical Research Unit (EOCRU) in Jakarta opened in 2008 with the signing of a memorandum of understanding between the Eijkman Institute for Molecular Biology and the University of Oxford, to conduct collaborative research on infectious diseases impacting the health of Indonesians and residents of other Southeast Asian nations. University of Oxford also has a partnership (MoU) with Universitas Indonesia, and they jointly established the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL) which is a facility dedicated to supporting collaborative clinical research between the universities. EOCRU is also part of the Oxford Tropical Network with research units in Africa, Asia and UK, and operates under the auspices of the Oxford University Clinical Research Unit in Vietnam.
Clinical trials of chemotherapeutics, diagnostics and vaccines for tropical infections of public health importance in Indonesia, principally malaria, tuberculosis, antimicrobial resistance, and other emerging and neglected tropical diseases, form the core of EOCRU’s activities, with associated epidemiological, laboratory, and clinical research. EOCRU aims to have a positive and significant impact on the prevention, diagnosis and treatment of infectious diseases to improve patient care in Indonesia and the region. This is being achieved via an expanding long-term research programme with our local hosts and partners, contributions to research training, and public engagement with science. Current EOCRU core staff includes 3 Oxford-employed expatriate scientists, Indonesian scientists, administrative and finance support staff, and clinical trials support staff.
In conducting their work in Indonesia, EOCRU is assisted by Alliance for Emerging and Re-emerging Disease Threats in Asia Foundation (ALERTAsia), a local foundation assisting in research grant management and capacity building for local researchers.
Through ALERTAsia we are seeking a qualified and experienced Assistant Researcher, based at EOCRU in Jakarta, to support several international research projects on the theme of antibiotic resistance and stewardship. These include (but may not be limited to) ongoing and planned projects on developing an assessment tool for antimicrobial stewardship (AMS) programs in hospitals in Asia, a surveillance project of hospital AMS program implemntation in Indonesia including the impact of COVID-19 an assessment. These projects are a partnership between the Faculty of Medicine University Indonesia, EOCRU, and several other national and international partners. The AR is a research professional who collects, edits, processes, and coordinates research data in support of the specified research study. S/he plays an important supporting role in the conduct of the studies under the supervision of the country Principal Investigator (PI), Senior Researcher, and will also work closely with the local study team.
Role and Responsibility:
The responsibilities of the full-time Assistant Researcher are providing research and field support for the country PI in conducting the study and will also work closely with a local and international study team. Specifically, the main responsibilities are listed below:
· Support developing and adapting data collection tools and standard operating procedures and other study materials.
· Work with local hospital and government partners to develop work plans to implement study protocols and identify research participants and sources for data collection.
· Use the data collection tools to collect data as required in collaboration with local partners: conduct and facilitate interviews, group discussions, observations, desk review and other qualitative and quantitative methods on site.
· Conduct literature review and data extraction following the study protocol.
· Perform data collection and cleaning.
· Assist with data analysis and reporting and writing academic papers.
· Transcribe and translate data obtained from interviews, discussions and observations where relevant.
· Use relevant software/programs to prepare and analyze qualitative data (including NVivo).
· Manage and administer project-specific budgets.
· Conduct and support training activities as needed.
· Translate research materials into local language and vice versa and provide language interpretation in meetings as required.
· Support the investigator to prepare for presentations and publication materials.
· Other study related tasks as required by the country PI.
Qualification:
Essential:
· Bachelor or Master degree in medicine (or a closely related field).
· Experience with quantitative and qualitative data collection for research studies.
· Experience working on health-related research studies.
· Excellent spoken and written English and Bahasa Indonesia.
· Attention to details and highly organized.
· Strong interpersonal and communication skills.
· Ability to work with a high degree of autonomy, and yet be a team player.
· Willingness to travel, interact with, and work in a range of hospital settings.
· Ability to work independently at home during COVID-19 outbreaks and using online applications for communication with supervisors and for work communication.
· Computer literacy and proficiency.
Desired:
· Experience working in hospital settings.
· Project management experience.
· Experience working with government stakeholders.
Starting of contract:
1 June 2022
Benefits
The selected candidate will receive a one-year contract with possible extension, and remuneration package that includes annual leave, sick leave, THR, compensation money, optional private medical cover, BPJS Kesehatan, and not to mention fully paid income tax and BPJS Ketenagakerjaan (JAMSOSTEK). The salary shall be competitive and dependent upon qualifications and salary history.
Duty Station
Jakarta
How to Apply
Application requirements (Cover Letter, CV, three names and addresses of professional referees, and your salary history) should be sent via email to: hro@alertasia.org. Please quote the reference “AR AMS” on your email subject.
Please submit your application no later than Saturday, 09 April 2022.
Thank you.
